The purpose of this study is to find out if a medicine called finerenone in combination with a medicine called empagliflozin is a safe and effective treatment for people that chronic kidney disease and type 2 diabetes.
Study visits will be like regular doctor appointments. At these visits, we will measure your vital signs (blood pressure, weight, height), conduct an ECG (test to measure heart function), the study doctor will complete a brief physical exam, and we will collect blood and urine samples.
$75
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Amy Mottl
Medicine-Nephrology
Clinical or Medical
Interventional
Diabetes
Kidneys and Liver
Rare Diseases
22-1479
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
